Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.13 trillion and total revenue of $110.89 billion.
Market Cap
1.13T
Revenue
110.89B
Profits
-39.37B
PE Ratio
n/a
Profit Margin
-35.51%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 109.19B | 1.42% | 291,018 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 71.90B | 2.96% | 332,923 | 14.92B |
| 3 | ARGX | argenx SE | 47.71B | 1.42% | 270,753 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.22B | 5.06% | 1,178,417 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 32.94B | 1.94% | 42,393 | 5.34B |
| 6 | RVMD | Revolution Medicines, Inc. | 29.75B | 0.65% | 809,590 | - |
| 7 | RPRX | Royalty Pharma plc | 29.75B | 1.40% | 1,686,802 | 2.38B |
| 8 | INSM | Insmed Incorporated | 29.40B | 0.88% | 379,369 | 606.42M |
| 9 | BNTX | BioNTech SE | 26.41B | 2.81% | 329,327 | 3.37B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.29B | 3.03% | 2,118,214 | 13.31M |
| 11 | INCY | Incyte Corporation | 19.76B | -0.18% | 367,156 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 18.54B | 2.25% | 2,204,073 | 1.94B |
| 13 | SMMT | Summit Therapeutics Inc. | 17.21B | 6.43% | 1,991,279 | - |
| 14 | GMAB | Genmab A/S | 15.90B | 1.74% | 599,718 | 3.72B |
| 15 | ASND | Ascendis Pharma A/S | 14.14B | 3.88% | 271,955 | 845.52M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 13.70B | -0.38% | 869,269 | 502.08M |
| 17 | JAZZ | Jazz Pharmaceuticals plc | 12.48B | 1.43% | 207,303 | 4.27B |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.38B | 0.17% | 716,509 | 1.06B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.88B | -0.16% | 50,240 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.49B | 1.23% | 371,474 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.57B | 0.90% | 396,242 | 3.22B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.10B | 2.28% | 317,706 | 1.09B |
| 23 | AXSM | Axsome Therapeutics, Inc. | 9.47B | 0.64% | 274,343 | 638.50M |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 8.93B | -0.77% | 112,982 | 7.46M |
| 25 | ABVX | ABIVAX Société Anonyme | 8.66B | 7.54% | 528,320 | 5.37M |
| 26 | TECH | Bio-Techne Corporation | 8.56B | 5.27% | 579,851 | 1.22B |
| 27 | PCVX | Vaxcyte, Inc. | 8.24B | -0.40% | 497,570 | - |
| 28 | CYTK | Cytokinetics, Incorporated | 7.84B | 5.89% | 821,371 | 88.04M |
| 29 | NUVL | Nuvalent, Inc. | 7.82B | 0.34% | 102,132 | - |
| 30 | KRYS | Krystal Biotech, Inc. | 7.69B | 0.51% | 46,961 | 389.13M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.60B | 1.76% | 406,891 | 1.40B |
| 32 | IBRX | ImmunityBio, Inc. | 7.34B | 2.08% | 3,244,397 | 113.29M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.63B | -0.33% | 301,656 | 51.48M |
| 34 | SYRE | Spyre Therapeutics, Inc. | 6.40B | 3.17% | 346,560 | - |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.31B | 0.30% | 119,502 | 46.02M |
| 36 | BLTE | Belite Bio, Inc | 6.15B | 1.13% | 23,163 | - |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.13B | 1.21% | 116,825 | - |
| 38 | TERN | Terns Pharmaceuticals, Inc. | 6.11B | 0.01% | 1,022,962 | - |
| 39 | COGT | Cogent Biosciences, Inc. | 6.10B | -0.42% | 364,522 | - |
| 40 | CNTA | Centessa Pharmaceuticals plc | 6.10B | -0.01% | 396,569 | 15.00M |
| 41 | CELC | Celcuity Inc. | 5.85B | 1.64% | 335,590 | - |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 5.84B | 1.68% | 204,185 | 521.31M |
| 43 | CGON | CG Oncology, Inc. | 5.61B | 2.67% | 215,540 | 4.04M |
| 44 | IMVT | Immunovant, Inc. | 5.59B | 1.86% | 505,889 | - |
| 45 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.58B | -0.43% | 60,759 | 189.76M |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.49B | -0.65% | 248,457 | - |
| 47 | PTCT | PTC Therapeutics, Inc. | 5.41B | 1.16% | 266,051 | 1.73B |
| 48 | XENE | Xenon Pharmaceuticals Inc. | 5.34B | -0.84% | 180,664 | 7.50M |
| 49 | CAI | Caris Life Sciences, Inc. | 5.31B | 5.74% | 479,092 | 812.03M |
| 50 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | -0.04% | 878,359 | 1.00B |
| 51 | TGTX | TG Therapeutics, Inc. | 5.03B | 1.40% | 385,545 | 616.29M |
| 52 | CORT | Corcept Therapeutics Incorporated | 5.03B | 0.49% | 228,779 | 761.41M |
| 53 | CRSP | CRISPR Therapeutics AG | 4.99B | 2.21% | 423,667 | 3.51M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.70B | 3.31% | 92,874 | 2.04M |
| 55 | LGND | Ligand Pharmaceuticals Incorporated | 4.47B | -0.89% | 44,566 | 268.09M |
| 56 | LEGN | Legend Biotech Corporation | 4.33B | 2.77% | 440,300 | 1.03B |
| 57 | KLRA | Kailera Therapeutics, Inc. | 4.26B | 2.14% | 159,557 | - |
| 58 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.02B | -0.05% | 188,911 | 7.70M |
| 59 | MANE | Veradermics, Incorporated | 3.85B | -3.14% | 775,730 | - |
| 60 | TVTX | Travere Therapeutics, Inc. | 3.84B | 3.72% | 1,174,804 | 490.73M |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 3.81B | 0.63% | 252,173 | 1.07B |
| 62 | TLX | Telix Pharmaceuticals Limited | 3.63B | 4.07% | 87,526 | 803.79M |
| 63 | VKTX | Viking Therapeutics, Inc. | 3.50B | -3.62% | 2,637,477 | - |
| 64 | ORKA | Oruka Therapeutics, Inc. | 3.45B | 0.85% | 1,533,607 | - |
| 65 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.41B | -1.31% | 889,054 | 588.99M |
| 66 | EWTX | Edgewise Therapeutics, Inc. | 3.29B | 0.53% | 166,386 | - |
| 67 | NAMS | NewAmsterdam Pharma Company N.V. | 3.27B | 0.18% | 146,514 | 22.50M |
| 68 | ERAS | Erasca, Inc. | 3.26B | 15.04% | 6,529,792 | - |
| 69 | TNGX | Tango Therapeutics, Inc. | 3.15B | -0.95% | 1,611,119 | 62.38M |
| 70 | BEAM | Beam Therapeutics Inc. | 3.09B | 5.07% | 504,917 | 139.74M |
| 71 | RCUS | Arcus Biosciences, Inc. | 3.08B | 1.53% | 104,466 | 247.00M |
| 72 | DNLI | Denali Therapeutics Inc. | 2.99B | 1.45% | 1,182,460 | - |
| 73 | ALMS | Alumis Inc. | 2.99B | 2.62% | 176,649 | 24.05M |
| 74 | DYN | Dyne Therapeutics, Inc. | 2.94B | 2.07% | 302,645 | - |
| 75 | GPCR | Structure Therapeutics Inc. | 2.93B | -0.35% | 415,088 | - |
| 76 | NKTR | Nektar Therapeutics | 2.87B | 2.34% | 340,310 | 55.23M |
| 77 | ARQT | Arcutis Biotherapeutics, Inc. | 2.86B | 2.24% | 468,116 | 376.07M |
| 78 | KOD | Kodiak Sciences Inc. | 2.75B | 1.42% | 98,283 | - |
| 79 | SLNO | Soleno Therapeutics, Inc. | 2.73B | 0.09% | 487,180 | 190.41M |
| 80 | IMNM | Immunome, Inc. | 2.63B | 1.18% | 291,369 | 6.94M |
| 81 | CLDX | Celldex Therapeutics, Inc. | 2.59B | 2.69% | 166,073 | 1.55M |
| 82 | TARS | Tarsus Pharmaceuticals, Inc. | 2.58B | -0.26% | 126,537 | 451.36M |
| 83 | VERA | Vera Therapeutics, Inc. | 2.54B | -1.31% | 252,670 | - |
| 84 | IDYA | IDEAYA Biosciences, Inc. | 2.54B | 2.92% | 237,473 | 218.71M |
| 85 | IRON | Disc Medicine, Inc. | 2.53B | 0.63% | 72,480 | - |
| 86 | ADMA | ADMA Biologics, Inc. | 2.51B | 1.75% | 772,010 | 510.17M |
| 87 | ELVN | Enliven Therapeutics, Inc. | 2.45B | -3.33% | 284,689 | - |
| 88 | RARE | Ultragenyx Pharmaceutical Inc. | 2.44B | 2.89% | 562,322 | 673.00M |
| 89 | RLAY | Relay Therapeutics, Inc. | 2.44B | 2.39% | 929,793 | 15.36M |
| 90 | ZLAB | Zai Lab Limited | 2.43B | 4.43% | 102,359 | 460.16M |
| 91 | SRPT | Sarepta Therapeutics, Inc. | 2.22B | 2.08% | 473,268 | 2.20B |
| 92 | MLYS | Mineralys Therapeutics, Inc. | 2.16B | 2.62% | 170,848 | - |
| 93 | ADPT | Adaptive Biotechnologies Corporation | 2.15B | 3.33% | 282,885 | 276.98M |
| 94 | AAPG | Ascentage Pharma Group International | 2.10B | 2.07% | 308 | 82.08M |
| 95 | DFTX | Definium Therapeutics, Inc. | 2.06B | 0.68% | 284,744 | - |
| 96 | TYRA | Tyra Biosciences, Inc. | 2.06B | 2.26% | 148,396 | - |
| 97 | STOK | Stoke Therapeutics, Inc. | 2.05B | 1.39% | 126,772 | 184.42M |
| 98 | ZYME | Zymeworks Inc. | 2.04B | -0.65% | 111,538 | 105.97M |
| 99 | AUPH | Aurinia Pharmaceuticals Inc. | 2.02B | 1.64% | 404,362 | 283.06M |
| 100 | OCUL | Ocular Therapeutix, Inc. | 2.01B | 0.33% | 763,954 | 51.95M |
| 101 | PHVS | Pharvaris N.V. | 1.98B | 1.68% | 250,886 | - |
| 102 | CAPR | Capricor Therapeutics, Inc. | 1.96B | 4.65% | 346,301 | 11.13M |
| 103 | MESO | Mesoblast Limited | 1.96B | 0.32% | 57,928 | 65.38M |
| 104 | TRVI | Trevi Therapeutics, Inc. | 1.89B | -2.53% | 1,374,482 | - |
| 105 | INBX | Inhibrx Biosciences, Inc. | 1.88B | 2.95% | 148,337 | 1.30M |
| 106 | RXRX | Recursion Pharmaceuticals, Inc. | 1.85B | 6.21% | 5,941,526 | 74.68M |
| 107 | SNDX | Syndax Pharmaceuticals, Inc. | 1.85B | 1.75% | 317,638 | 172.35M |
| 108 | TSHA | Taysha Gene Therapies, Inc. | 1.85B | 2.71% | 511,320 | 9.77M |
| 109 | GLPG | Galapagos NV | 1.85B | 1.01% | 55,702 | 1.31B |
| 110 | ANAB | AnaptysBio, Inc. | 1.83B | 1.88% | 75,148 | 234.60M |
| 111 | PVLA | Palvella Therapeutics, Inc. | 1.81B | 3.55% | 37,838 | - |
| 112 | HRMY | Harmony Biosciences Holdings, Inc. | 1.80B | 0.10% | 136,813 | 868.45M |
| 113 | VCEL | Vericel Corporation | 1.74B | 2.30% | 212,948 | 276.26M |
| 114 | SION | Sionna Therapeutics, Inc. | 1.73B | 2.14% | 50,868 | - |
| 115 | NRIX | Nurix Therapeutics, Inc. | 1.71B | -0.18% | 220,554 | 71.78M |
| 116 | INVA | Innoviva, Inc. | 1.71B | 0.04% | 141,779 | 411.33M |
| 117 | VIR | Vir Biotechnology, Inc. | 1.67B | 2.78% | 375,310 | 68.56M |
| 118 | AGIO | Agios Pharmaceuticals, Inc. | 1.66B | 0.82% | 361,778 | 66.05M |
| 119 | GENB | Generate Biomedicines, Inc. | 1.63B | 3.31% | 58,784 | 31.89M |
| 120 | NTLA | Intellia Therapeutics, Inc. | 1.61B | 9.60% | 7,167,446 | 67.67M |
| 121 | NBTX | Nanobiotix S.A. | 1.60B | 2.76% | 69,618 | 38.27M |
| 122 | RAPP | Rapport Therapeutics, Inc. | 1.59B | 0.97% | 194,734 | - |
| 123 | OCS | Oculis Holding AG | 1.59B | 1.74% | 1,217,999 | 1.51M |
| 124 | DMRA | Damora Therapeutics, Inc. | 1.53B | 6.23% | 29,988 | - |
| 125 | ARDX | Ardelyx, Inc. | 1.53B | 3.83% | 2,473,810 | 407.32M |
| 126 | NUVB | Nuvation Bio Inc. | 1.53B | 1.38% | 1,639,629 | 62.90M |
| 127 | GLUE | Monte Rosa Therapeutics, Inc. | 1.52B | 1.44% | 126,688 | 123.67M |
| 128 | IMTX | Immatics N.V. | 1.51B | 0.71% | 101,321 | 56.67M |
| 129 | ATAI | AtaiBeckley Inc. | 1.49B | -1.58% | 1,638,182 | 4.09M |
| 130 | PGEN | Precigen, Inc. | 1.49B | 1.94% | 980,195 | 9.68M |
| 131 | MAZE | Maze Therapeutics, Inc. | 1.47B | 3.54% | 150,288 | 2.50M |
| 132 | IMCR | Immunocore Holdings plc | 1.43B | 0.61% | 38,896 | 400.02M |
| 133 | BCAX | Bicara Therapeutics Inc. | 1.42B | 1.69% | 55,639 | - |
| 134 | BHVN | Biohaven Ltd. | 1.41B | 2.01% | 372,348 | - |
| 135 | MBX | MBX Biosciences, Inc. | 1.41B | 3.64% | 104,262 | - |
| 136 | IOVA | Iovance Biotherapeutics, Inc. | 1.40B | 2.42% | 5,235,543 | 263.50M |
| 137 | VRDN | Viridian Therapeutics, Inc. | 1.38B | 0.75% | 356,601 | 70.85M |
| 138 | MPLT | MapLight Therapeutics, Inc. | 1.38B | 3.17% | 52,980 | - |
| 139 | KALV | KalVista Pharmaceuticals, Inc. | 1.37B | 0.02% | 7,099,245 | 73.62M |
| 140 | WVE | Wave Life Sciences Ltd. | 1.36B | 0.50% | 1,141,682 | 71.80M |
| 141 | AVBP | ArriVent BioPharma, Inc. | 1.36B | 2.38% | 109,260 | - |
| 142 | NVAX | Novavax, Inc. | 1.33B | 2.45% | 1,006,751 | 1.12B |
| 143 | SVRA | Savara Inc. | 1.27B | 3.61% | 518,367 | - |
| 144 | QURE | uniQure N.V. | 1.26B | 19.61% | 2,209,062 | 16.10M |
| 145 | OLMA | Olema Pharmaceuticals, Inc. | 1.26B | 2.19% | 276,480 | - |
| 146 | CRVS | Corvus Pharmaceuticals, Inc. | 1.26B | 3.74% | 236,141 | - |
| 147 | DBVT | DBV Technologies S.A. | 1.24B | 3.10% | 143,180 | 5.64M |
| 148 | GHRS | GH Research PLC | 1.24B | 4.44% | 19,571 | - |
| 149 | ABCL | AbCellera Biologics Inc. | 1.23B | 6.41% | 2,489,521 | 75.13M |
| 150 | JBIO | Jade Biosciences, Inc. | 1.19B | 8.06% | 224,708 | - |
| 151 | MLTX | MoonLake Immunotherapeutics | 1.17B | 1.55% | 145,896 | - |
| 152 | PHAR | Pharming Group N.V. | 1.17B | 0.92% | 1,806 | 376.13M |
| 153 | URGN | UroGen Pharma Ltd. | 1.14B | 0.36% | 141,005 | 109.79M |
| 154 | ZBIO | Zenas BioPharma, Inc. | 1.09B | 4.84% | 246,712 | 10.00M |
| 155 | EYPT | EyePoint, Inc. | 1.09B | 1.32% | 209,661 | 31.37M |
| 156 | AKTS | Aktis Oncology, Inc. | 1.07B | 3.74% | 49,996 | 6.50M |
| 157 | FTRE | Fortrea Holdings Inc. | 1.07B | 7.95% | 558,654 | 2.72B |
| 158 | OMER | Omeros Corporation | 1.06B | 1.30% | 271,342 | - |
| 159 | XERS | Xeris Biopharma Holdings, Inc. | 1.06B | 1.58% | 358,034 | 291.85M |
| 160 | SEPN | Septerna, Inc. | 1.05B | 0.09% | 50,511 | 45.95M |
| 161 | IVA | Inventiva S.A. | 1.02B | 3.54% | 88,347 | 7.94M |
| 162 | GERN | Geron Corporation | 977.37M | 0.99% | 6,421,900 | 183.88M |
| 163 | ANNX | Annexon, Inc. | 968.54M | 1.19% | 632,428 | - |
| 164 | ORIC | ORIC Pharmaceuticals, Inc. | 961.43M | 1.48% | 181,496 | - |
| 165 | MRVI | Maravai LifeSciences Holdings, Inc. | 940.87M | 5.17% | 334,527 | 185.74M |
| 166 | SLS | SELLAS Life Sciences Group, Inc. | 918.97M | 6.64% | 1,904,948 | - |
| 167 | SANA | Sana Biotechnology, Inc. | 915.04M | 2.62% | 955,344 | - |
| 168 | LBRX | LB Pharmaceuticals Inc | 901.56M | 2.78% | 50,514 | - |
| 169 | EVMN | Evommune, Inc. | 887.49M | 3.31% | 109,249 | 13.00M |
| 170 | CTMX | CytomX Therapeutics, Inc. | 883.84M | 0.25% | 1,394,490 | 76.20M |
| 171 | JANX | Janux Therapeutics, Inc. | 874.76M | 1.91% | 216,784 | 10.00M |
| 172 | MNKD | MannKind Corporation | 873.89M | 2.91% | 1,414,992 | 348.97M |
| 173 | XNCR | Xencor, Inc. | 870.53M | 2.15% | 108,725 | 125.58M |
| 174 | MGTX | MeiraGTx Holdings plc | 866.34M | 4.58% | 223,234 | 81.39M |
| 175 | DRUG | Bright Minds Biosciences Inc. | 865.62M | -0.32% | 49,797 | - |
| 176 | DSGN | Design Therapeutics, Inc. | 861.69M | -12.60% | 427,324 | - |
| 177 | PHAT | Phathom Pharmaceuticals, Inc. | 859.43M | -8.15% | 2,001,034 | 204.89M |
| 178 | TBPH | Theravance Biopharma, Inc. | 853.75M | -0.54% | 57,369 | 107.46M |
| 179 | ANRO | Alto Neuroscience, Inc. | 838.11M | -1.60% | 63,091 | - |
| 180 | ABUS | Arbutus Biopharma Corporation | 826.16M | 1.57% | 329,378 | 14.08M |
| 181 | VOR | Vor Biopharma Inc. | 800.86M | 5.35% | 205,696 | - |
| 182 | TRAX | First Tracks Biotherapeutics, Inc. | 792.10M | -3.57% | 168,472 | - |
| 183 | KURA | Kura Oncology, Inc. | 790.88M | 1.83% | 214,950 | 67.48M |
| 184 | SPRY | ARS Pharmaceuticals, Inc. | 778.99M | 0.06% | 318,681 | 84.28M |
| 185 | CGEM | Cullinan Therapeutics, Inc. | 778.37M | 0.08% | 82,969 | - |
| 186 | TENX | Tenax Therapeutics, Inc. | 776.60M | 3.21% | 177,907 | - |
| 187 | ABSI | Absci Corporation | 771.02M | 5.31% | 2,691,529 | 2.80M |
| 188 | RLMD | Relmada Therapeutics, Inc. | 769.88M | -0.41% | 304,439 | - |
| 189 | SGP | SpyGlass Pharma, Inc. | 752.43M | 1.72% | 32,815 | - |
| 190 | ALLO | Allogene Therapeutics, Inc. | 734.39M | 1.18% | 1,572,302 | 22.00K |
| 191 | SLDB | Solid Biosciences Inc. | 716.45M | 3.26% | 234,521 | - |
| 192 | CBIO | Crescent Biopharma, Inc. | 710.77M | 2.15% | 104,122 | 10.84M |
| 193 | GYRE | Gyre Therapeutics, Inc. | 699.47M | 4.22% | 19,006 | 116.59M |
| 194 | LXRX | Lexicon Pharmaceuticals, Inc. | 684.24M | 4.19% | 566,135 | 49.80M |
| 195 | DRTS | Alpha Tau Medical Ltd. | 683.84M | 5.43% | 206,561 | - |
| 196 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 670.68M | 3.97% | 111,902 | - |
| 197 | FBRX | Forte Biosciences, Inc. | 669.85M | -2.37% | 45,044 | - |
| 198 | PRME | Prime Medicine, Inc. | 643.03M | 2.83% | 663,153 | 4.63M |
| 199 | ARVN | Arvinas, Inc. | 634.49M | 1.02% | 200,439 | 262.60M |
| 200 | STRO | Sutro Biopharma, Inc. | 619.14M | 5.59% | 56,473 | 102.48M |
| 201 | ACRS | Aclaris Therapeutics, Inc. | 616.62M | -1.23% | 679,168 | 7.83M |
| 202 | ZVRA | Zevra Therapeutics, Inc. | 602.97M | 5.48% | 416,209 | 106.47M |
| 203 | CRMD | CorMedix Inc. | 595.27M | 1.47% | 218,953 | 311.71M |
| 204 | PRTA | Prothena Corporation plc | 594.59M | 1.61% | 83,494 | 9.68M |
| 205 | OCGN | Ocugen, Inc. | 578.86M | 1.79% | 2,192,126 | 4.41M |
| 206 | PROK | ProKidney Corp. | 569.20M | 3.57% | 395,201 | 893.00K |
| 207 | STTK | Shattuck Labs, Inc. | 552.88M | 3.17% | 118,212 | 1.00M |
| 208 | RIGL | Rigel Pharmaceuticals, Inc. | 550.70M | 1.98% | 76,670 | 294.28M |
| 209 | KYTX | Kyverna Therapeutics, Inc. | 542.35M | 6.67% | 283,829 | - |
| 210 | ANL | Adlai Nortye Ltd. | 527.60M | -6.39% | 193,832 | 5.00M |
| 211 | TECX | Tectonic Therapeutic, Inc. | 523.30M | 2.96% | 36,189 | - |
| 212 | AGMB | AgomAb Therapeutics NV | 514.90M | -1.63% | 32,179 | - |
| 213 | EIKN | Eikon Therapeutics, Inc. | 511.61M | 3.73% | 86,403 | - |
| 214 | ALT | Altimmune, Inc. | 505.89M | -0.95% | 2,519,354 | 41.00K |
| 215 | UPB | Upstream Bio, Inc. | 496.31M | -0.76% | 135,684 | 2.85M |
| 216 | XOMA | XOMA Royalty Corporation | 495.34M | 1.41% | 68,025 | 52.15M |
| 217 | MDXG | MiMedx Group, Inc. | 491.76M | 7.29% | 1,859,734 | 389.42M |
| 218 | DNA | Ginkgo Bioworks Holdings, Inc. | 490.11M | 12.27% | 437,515 | 170.16M |
| 219 | PRLD | Prelude Therapeutics Incorporated | 482.65M | 12.41% | 186,506 | 12.14M |
| 220 | CTNM | Contineum Therapeutics, Inc. | 482.57M | 7.35% | 64,450 | - |
| 221 | ADCT | ADC Therapeutics SA | 481.41M | 0.13% | 222,196 | 81.36M |
| 222 | ENGN | enGene Therapeutics Inc. | 480.65M | 1.92% | 56,655 | - |
| 223 | TRDA | Entrada Therapeutics, Inc. | 480.24M | 4.87% | 156,611 | 25.42M |
| 224 | OVID | Ovid Therapeutics Inc. | 479.31M | 2.97% | 652,711 | 7.25M |
| 225 | VSTM | Verastem, Inc. | 478.74M | 0.93% | 284,554 | 30.91M |
| 226 | FULC | Fulcrum Therapeutics, Inc. | 475.76M | -0.14% | 202,327 | 80.00M |
| 227 | LYEL | Lyell Immunopharma, Inc. | 474.50M | -1.26% | 11,811 | 36.00K |
| 228 | ZURA | Zura Bio Limited | 473.45M | -0.40% | 121,779 | - |
| 229 | VALN | Valneva SE | 473.10M | 2.06% | 24,516 | 205.07M |
| 230 | RGNX | REGENXBIO Inc. | 463.01M | 6.79% | 187,848 | 170.44M |
| 231 | IMMX | Immix Biopharma, Inc. | 461.74M | 0.93% | 371,740 | - |
| 232 | CADL | Candel Therapeutics, Inc. | 459.26M | 1.46% | 614,150 | - |
| 233 | FDMT | 4D Molecular Therapeutics, Inc. | 457.42M | 1.70% | 315,947 | 85.21M |
| 234 | EPRX | Eupraxia Pharmaceuticals Inc. | 454.46M | 6.06% | 113,448 | - |
| 235 | LRMR | Larimar Therapeutics, Inc. | 442.54M | -1.84% | 453,609 | - |
| 236 | AVIR | Atea Pharmaceuticals, Inc. | 438.20M | 1.29% | 56,701 | - |
| 237 | AURA | Aura Biosciences, Inc. | 432.71M | 0.15% | 39,899 | - |
| 238 | LXEO | Lexeo Therapeutics, Inc. | 426.74M | 1.41% | 140,415 | - |
| 239 | BNTC | Benitec Biopharma Inc. | 423.90M | 1.85% | 29,327 | - |
| 240 | NMRA | Neumora Therapeutics, Inc. | 423.84M | 3.11% | 243,867 | - |
| 241 | ASMB | Assembly Biosciences, Inc. | 422.11M | 0.87% | 18,056 | 72.30M |
| 242 | VNDA | Vanda Pharmaceuticals Inc. | 419.08M | 0.57% | 331,070 | 216.11M |
| 243 | CLYM | Climb Bio, Inc. | 409.14M | -2.45% | 424,113 | - |
| 244 | PRTC | PureTech Health plc | 409.08M | -0.29% | 3,957 | 6.39M |
| 245 | IPSC | Century Therapeutics, Inc. | 406.93M | 2.73% | 125,858 | 109.16M |
| 246 | NGNE | Neurogene Inc. | 403.20M | -2.49% | 24,472 | 925.00K |
| 247 | ENTA | Enanta Pharmaceuticals, Inc. | 401.05M | -0.36% | 70,914 | 66.98M |
| 248 | IVVD | Invivyd, Inc. | 397.34M | 3.31% | 260,682 | 53.43M |
| 249 | VTVT | vTv Therapeutics Inc. | 388.42M | 0.10% | 7,994 | 17.00K |
| 250 | PBYI | Puma Biotechnology, Inc. | 386.66M | 1.60% | 39,802 | 228.37M |
| 251 | RCKT | Rocket Pharmaceuticals, Inc. | 379.75M | - | 579,770 | - |
| 252 | AUTL | Autolus Therapeutics plc | 379.25M | 1.06% | 339,577 | 75.39M |
| 253 | ARMP | Armata Pharmaceuticals, Inc. | 377.32M | 7.85% | 37,295 | 4.90M |
| 254 | NAGE | Niagen Bioscience, Inc. | 376.36M | -1.47% | 140,741 | 129.42M |
| 255 | XFOR | X4 Pharmaceuticals, Inc. | 375.50M | 0.73% | 74,479 | 35.11M |
| 256 | LCTX | Lineage Cell Therapeutics, Inc. | 372.39M | 2.40% | 1,050,802 | 14.56M |
| 257 | SRZN | Surrozen, Inc. | 367.46M | 1.36% | 21,147 | 3.48M |
| 258 | IRD | Opus Genetics, Inc. | 362.72M | 8.78% | 912,497 | 14.20M |
| 259 | YDES | YD Bio Limited | 360.04M | -1.34% | 532 | 510.36K |
| 260 | MNPR | Monopar Therapeutics Inc. | 358.43M | 6.86% | 26,318 | - |
| 261 | AVTX | Avalo Therapeutics, Inc. | 355.57M | 0.83% | 330,618 | 59.00K |
| 262 | SLN | Silence Therapeutics plc | 345.28M | 2.81% | 39,719 | 559.00K |
| 263 | RZLT | Rezolute, Inc. | 338.10M | 4.33% | 385,659 | - |
| 264 | IMRX | Immuneering Corporation | 337.07M | -0.76% | 353,974 | - |
| 265 | PALI | Palisade Bio, Inc. | 331.50M | 2.59% | 738,142 | - |
| 266 | NAUT | Nautilus Biotechnology, Inc. | 329.07M | 4.00% | 79,813 | - |
| 267 | BCYC | Bicycle Therapeutics plc | 328.32M | -0.42% | 368,625 | 72.59M |
| 268 | CABA | Cabaletta Bio, Inc. | 327.29M | 5.76% | 954,589 | - |
| 269 | IKT | Inhibikase Therapeutics, Inc. | 325.56M | 2.69% | 207,652 | 1.00 |
| 270 | GLSI | Greenwich LifeSciences, Inc. | 322.67M | 7.82% | 53,453 | - |
| 271 | CMPX | Compass Therapeutics, Inc. | 318.76M | 5.99% | 5,325,709 | 850.00K |
| 272 | DMAC | DiaMedica Therapeutics Inc. | 318.18M | -0.92% | 65,160 | - |
| 273 | AVXL | Anavex Life Sciences Corp. | 315.08M | 4.29% | 247,874 | - |
| 274 | ABEO | Abeona Therapeutics Inc. | 312.57M | 2.90% | 317,249 | 5.82M |
| 275 | NGEN | NervGen Pharma Corp. | 301.87M | -0.53% | 110,092 | - |
| 276 | ACIU | AC Immune SA | 300.58M | 3.41% | 114,632 | 4.51M |
| 277 | EDIT | Editas Medicine, Inc. | 297.53M | 7.80% | 639,031 | 40.52M |
| 278 | LENZ | LENZ Therapeutics, Inc. | 289.71M | 2.10% | 455,872 | 19.09M |
| 279 | ZNTL | Zentalis Pharmaceuticals, Inc. | 280.89M | - | 242,143 | 26.87M |
| 280 | TARA | Protara Therapeutics, Inc. | 280.70M | 0.39% | 186,748 | - |
| 281 | NERV | Minerva Neurosciences, Inc. | 280.59M | 0.16% | 68,730 | - |
| 282 | CHRS | Coherus Oncology, Inc. | 277.59M | 3.45% | 220,703 | 42.17M |
| 283 | FHTX | Foghorn Therapeutics Inc. | 276.48M | -1.05% | 50,631 | 30.91M |
| 284 | CLLS | Cellectis S.A. | 273.38M | 3.75% | 8,024 | 79.59M |
| 285 | NBP | NovaBridge Biosciences | 271.20M | -0.21% | 2,307,192 | - |
| 286 | ELDN | Eledon Pharmaceuticals, Inc. | 268.92M | 5.99% | 621,245 | - |
| 287 | SGMT | Sagimet Biosciences Inc. | 267.20M | -4.65% | 460,002 | - |
| 288 | ALEC | Alector, Inc. | 265.97M | 4.78% | 436,235 | 21.05M |
| 289 | CCCC | C4 Therapeutics, Inc. | 261.51M | 4.69% | 554,549 | 35.95M |
| 290 | SABS | SAB Biotherapeutics, Inc. | 260.72M | 6.61% | 471,630 | 114.70K |
| 291 | CDXS | Codexis, Inc. | 257.61M | 0.89% | 316,172 | 70.39M |
| 292 | HELP | Cybin Inc. | 253.93M | 3.36% | 366,470 | - |
| 293 | ARCT | Arcturus Therapeutics Holdings Inc. | 248.99M | 4.29% | 112,303 | 82.03M |
| 294 | CGEN | Compugen Ltd. | 247.26M | 0.58% | 197,331 | 72.76M |
| 295 | PLYX | Polaryx Therapeutics, Inc. | 245.71M | -0.57% | 42,436 | - |
| 296 | ADAG | Adagene Inc. | 240.17M | 2.39% | 24,884 | 7.67M |
| 297 | ARTV | Artiva Biotherapeutics, Inc. | 235.55M | 9.29% | 94,893 | 251.00K |
| 298 | SLGL | Sol-Gel Technologies Ltd. | 233.41M | - | 4,918 | 19.39M |
| 299 | OBIO | Orchestra BioMed Holdings, Inc. | 232.91M | 4.74% | 162,562 | 33.48M |
| 300 | ACHV | Achieve Life Sciences, Inc. | 228.93M | 3.61% | 554,906 | - |
| 301 | NVCT | Nuvectis Pharma, Inc. | 226.50M | 0.59% | 24,831 | - |
| 302 | HRTX | Heron Therapeutics, Inc. | 226.37M | 0.84% | 467,146 | 154.90M |
| 303 | ALXO | ALX Oncology Holdings Inc. | 222.70M | 4.75% | 119,949 | - |
| 304 | MIST | Milestone Pharmaceuticals Inc. | 222.00M | -0.55% | 347,963 | 1.55M |
| 305 | VYGR | Voyager Therapeutics, Inc. | 220.52M | 1.65% | 100,301 | 40.37M |
| 306 | FENC | Fennec Pharmaceuticals Inc. | 219.26M | 1.60% | 36,226 | 44.64M |
| 307 | KROS | Keros Therapeutics, Inc. | 219.25M | -0.18% | 46,797 | 244.06M |
| 308 | CAMP | Camp4 Therapeutics Corporation | 215.49M | 3.49% | 25,059 | 3.50M |
| 309 | CNTX | Context Therapeutics Inc. | 213.16M | -0.85% | 328,480 | - |
| 310 | OKUR | OnKure Therapeutics, Inc. | 210.46M | 2.16% | 35,659 | - |
| 311 | MDWD | MediWound Ltd. | 210.42M | 0.75% | 8,572 | 16.96M |
| 312 | NKTX | Nkarta, Inc. | 201.04M | 4.83% | 358,872 | - |
| 313 | REPL | Replimune Group, Inc. | 199.83M | 1.68% | 868,272 | - |
| 314 | OABI | OmniAb, Inc. | 199.08M | 1.10% | 72,697 | 18.67M |
| 315 | WHWK | Whitehawk Therapeutics, Inc. | 197.05M | 3.34% | 65,849 | 7.15M |
| 316 | MGNX | MacroGenics, Inc. | 197.04M | 5.44% | 153,673 | 149.50M |
| 317 | KPTI | Karyopharm Therapeutics Inc. | 192.29M | 1.55% | 108,167 | 146.07M |
| 318 | ENLV | Enlivex Ltd. | 190.32M | 0.03% | 107,576 | - |
| 319 | ELTX | Elicio Therapeutics, Inc. | 189.39M | -0.24% | 59,193 | - |
| 320 | KRRO | Korro Bio, Inc. | 189.37M | 4.12% | 20,419 | 6.39M |
| 321 | HUMA | Humacyte, Inc. | 186.05M | 2.20% | 1,662,961 | 2.04M |
| 322 | CRBU | Caribou Biosciences, Inc. | 185.06M | -0.26% | 563,850 | 11.16M |
| 323 | UNCY | Unicycive Therapeutics, Inc. | 182.72M | 1.12% | 188,498 | - |
| 324 | TNXP | Tonix Pharmaceuticals Holding Corp. | 180.55M | 2.50% | 99,794 | 13.11M |
| 325 | DTIL | Precision BioSciences, Inc. | 179.59M | 0.87% | 36,782 | 34.26M |
| 326 | CNTN | Canton Strategic Holdings, Inc. | 177.90M | 0.64% | 264,071 | - |
| 327 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 177.90M | 2.14% | 149,274 | - |
| 328 | ABOS | Acumen Pharmaceuticals, Inc. | 174.68M | 3.37% | 105,331 | - |
| 329 | PLX | Protalix BioTherapeutics, Inc. | 172.83M | 1.18% | 76,277 | 52.74M |
| 330 | PRQR | ProQR Therapeutics N.V. | 172.79M | 6.49% | 176,388 | 19.19M |
| 331 | MENS | Jyong Biotech Ltd. | 172.26M | 2.75% | 29,726 | - |
| 332 | RNAC | Cartesian Therapeutics, Inc. | 171.12M | -0.23% | 47,501 | 1.78M |
| 333 | ANTX | AN2 Therapeutics, Inc. | 166.66M | -1.07% | 81,394 | - |
| 334 | TLSA | Tiziana Life Sciences Ltd | 160.81M | - | 37,950 | - |
| 335 | MOLN | Molecular Partners AG | 159.10M | -4.49% | 474 | 856.30K |
| 336 | ORMP | Oramed Pharmaceuticals Inc. | 156.53M | 0.78% | 55,358 | 2.00M |
| 337 | SPRB | Spruce Biosciences, Inc. | 155.25M | 3.48% | 16,168 | 697.00K |
| 338 | KZIA | Kazia Therapeutics Limited | 155.06M | 9.26% | 150,050 | 1.27M |
| 339 | AGEN | Agenus Inc. | 153.59M | 4.17% | 277,565 | 114.20M |
| 340 | BDTX | Black Diamond Therapeutics, Inc. | 152.39M | 3.50% | 291,488 | 70.00M |
| 341 | GALT | Galectin Therapeutics Inc. | 150.74M | 1.78% | 117,799 | - |
| 342 | TNYA | Tenaya Therapeutics, Inc. | 150.73M | 5.19% | 2,103,198 | - |
| 343 | ALPS | Alps Group Inc | 149.76M | -3.23% | 56,991 | 3.74M |
| 344 | SPRO | Spero Therapeutics, Inc. | 149.07M | 1.78% | 145,556 | 66.80M |
| 345 | FATE | Fate Therapeutics, Inc. | 146.49M | 1.61% | 335,319 | 6.65M |
| 346 | IFRX | InflaRx N.V. | 143.86M | 0.51% | 645,348 | 34.44K |
| 347 | CNTB | Connect Biopharma Holdings Limited | 141.30M | -1.19% | 33,694 | 64.00K |
| 348 | HURA | TuHURA Biosciences, Inc. | 139.87M | 4.76% | 283,490 | - |
| 349 | EDSA | Edesa Biotech, Inc. | 137.73M | -2.52% | 340,276 | - |
| 350 | EQ | Equillium, Inc. | 131.20M | -0.24% | 37,612 | 4.39M |
| 351 | IPHA | Innate Pharma S.A. | 131.03M | -1.35% | 34,031 | 10.57M |
| 352 | KLRS | Kalaris Therapeutics, Inc. | 126.33M | - | 51,284 | - |
| 353 | ACOG | Alpha Cognition Inc. | 126.12M | -1.33% | 8,613 | 10.22M |
| 354 | IMUX | Immunic, Inc. | 125.26M | -8.18% | 230,210 | - |
| 355 | CRDF | Cardiff Oncology, Inc. | 117.25M | 5.86% | 340,760 | 593.00K |
| 356 | GNLX | Genelux Corporation | 117.14M | 5.60% | 91,419 | 8.00K |
| 357 | AARD | Aardvark Therapeutics, Inc. | 115.40M | 1.53% | 34,733 | - |
| 358 | VANI | Vivani Medical, Inc. | 113.85M | 1.89% | 28,387 | - |
| 359 | PEPG | PepGen Inc. | 113.35M | 5.81% | 248,077 | - |
| 360 | VRCA | Verrica Pharmaceuticals Inc. | 112.95M | -0.08% | 1,804 | 35.58M |
| 361 | CGTX | Cognition Therapeutics, Inc. | 109.46M | 3.81% | 313,455 | - |
| 362 | PYXS | Pyxis Oncology, Inc. | 109.01M | 4.52% | 186,140 | 13.86M |
| 363 | NTHI | NeOnc Technologies Holdings, Inc. | 108.86M | 1.63% | 25,926 | 39.99K |
| 364 | SEER | Seer, Inc. | 108.61M | 2.39% | 86,799 | 16.58M |
| 365 | ONCY | Oncolytics Biotech Inc. | 108.59M | 7.36% | 406,674 | - |
| 366 | BMEA | Biomea Fusion, Inc. | 107.36M | 2.41% | 336,611 | - |
| 367 | CBUS | Cibus, Inc. | 106.41M | 8.98% | 250,993 | 3.64M |
| 368 | TTRX | Turn Therapeutics Inc. | 105.87M | -0.02% | 7,070 | - |
| 369 | KALA | KALA BIO, Inc. | 101.87M | 0.18% | 1,937,820 | - |
| 370 | ANIX | Anixa Biosciences, Inc. | 99.91M | 3.47% | 42,046 | - |
| 371 | GUTS | Fractyl Health, Inc. | 99.39M | 4.07% | 744,164 | 3.00K |
| 372 | NRXP | NRx Pharmaceuticals, Inc. | 98.77M | 2.75% | 646,167 | 1.23M |
| 373 | PMN | ProMIS Neurosciences, Inc. | 98.67M | -1.32% | 9,456 | - |
| 374 | COYA | Coya Therapeutics, Inc. | 97.58M | 2.21% | 16,287 | 7.95M |
| 375 | ALDX | Aldeyra Therapeutics, Inc. | 92.98M | 3.00% | 276,457 | - |
| 376 | INO | Inovio Pharmaceuticals, Inc. | 92.18M | 0.45% | 159,060 | 65.34K |
| 377 | RANI | Rani Therapeutics Holdings, Inc. | 89.76M | 2.95% | 172,702 | 1.63M |
| 378 | LONA | LeonaBio, Inc. | 87.17M | 5.82% | 6,687 | - |
| 379 | PYPD | PolyPid Ltd. | 86.83M | 0.44% | 4,222 | - |
| 380 | NRXS | NeurAxis, Inc. | 85.60M | - | 38,680 | 3.57M |
| 381 | EXOZ | eXoZymes, Inc. | 84.79M | -3.38% | 4,975 | -700.00 |
| 382 | PTHS | Pelthos Therapeutics Inc. | 83.79M | -0.48% | 8,581 | 16.80M |
| 383 | MAIA | MAIA Biotechnology, Inc. | 83.42M | 5.77% | 353,997 | - |
| 384 | GOSS | Gossamer Bio, Inc. | 82.43M | 0.46% | 1,264,061 | 48.47M |
| 385 | ACET | Adicet Bio, Inc. | 82.34M | 0.39% | 22,360 | - |
| 386 | OKYO | OKYO Pharma Limited | 81.88M | 2.64% | 14,612 | - |
| 387 | CSBR | Champions Oncology, Inc. | 80.68M | -0.69% | 311 | 57.95M |
| 388 | QTTB | Q32 Bio Inc. | 80.46M | - | 112,611 | 53.74M |
| 389 | GANX | Gain Therapeutics, Inc. | 78.57M | 5.69% | 262,072 | - |
| 390 | ATYR | aTyr Pharma, Inc. | 77.80M | 3.73% | 292,017 | 190.00K |
| 391 | ATHE | Alterity Therapeutics Limited | 77.59M | 0.99% | 8,743 | 4.43M |
| 392 | XBIT | XBiotech Inc. | 76.83M | - | 32,434 | - |
| 393 | ICCC | ImmuCell Corporation | 75.99M | -0.47% | 5,173 | 27.64M |
| 394 | PLRX | Pliant Therapeutics, Inc. | 75.23M | 0.41% | 100,880 | - |
| 395 | PMVP | PMV Pharmaceuticals, Inc. | 74.66M | 0.72% | 49,774 | - |
| 396 | FBIO | Fortress Biotech, Inc. | 73.58M | 2.93% | 64,554 | 63.26M |
| 397 | OSTX | OS Therapies Incorporated | 73.15M | 6.75% | 917,137 | - |
| 398 | FLNA | Filana Therapeutics, Inc. | 71.25M | 2.43% | 62,658 | - |
| 399 | TCRX | TScan Therapeutics, Inc. | 70.62M | 2.17% | 150,432 | 10.33M |
| 400 | ACRV | Acrivon Therapeutics, Inc. | 70.51M | 0.55% | 213,045 | - |
| 401 | MCRB | Seres Therapeutics, Inc. | 70.46M | 4.26% | 14,698 | 789.00K |
| 402 | IBO | Impact BioMedical Inc. | 69.22M | -2.73% | 24,382 | 32.00K |
| 403 | ACTU | Actuate Therapeutics, Inc. | 69.12M | 1.22% | 43,811 | - |
| 404 | MNOV | MediciNova, Inc. | 67.96M | 0.78% | 7,565 | 409.66K |
| 405 | IMA | ImageneBio, Inc. | 67.00M | 1.01% | 9,253 | 800.00K |
| 406 | ANVS | Annovis Bio, Inc. | 66.99M | 5.43% | 420,177 | - |
| 407 | ESLA | Estrella Immunopharma, Inc. | 65.06M | 3.74% | 9,251 | - |
| 408 | BYSI | BeyondSpring Inc. | 62.51M | 3.41% | 2,951 | 1.88M |
| 409 | IMMP | Immutep Limited | 62.48M | 0.16% | 478,944 | 5.28M |
| 410 | INKT | MiNK Therapeutics, Inc. | 60.04M | 2.37% | 4,978 | - |
| 411 | CING | Cingulate Inc. | 59.89M | 9.34% | 241,745 | - |
| 412 | HYFT | MindWalk Holdings Corp. | 58.64M | -0.78% | 23,861 | 20.70M |
| 413 | IBIO | iBio, Inc. | 58.01M | -0.93% | 495,145 | 300.00K |
| 414 | PDSB | PDS Biotechnology Corporation | 56.09M | 4.65% | 237,477 | - |
| 415 | TIL | Instil Bio, Inc. | 55.00M | 3.31% | 7,073 | - |
| 416 | KZR | Kezar Life Sciences, Inc. | 53.86M | -0.14% | 61,822 | - |
| 417 | ENTX | Entera Bio Ltd. | 53.85M | 3.12% | 24,506 | 42.00K |
| 418 | MGX | Metagenomi Therapeutics, Inc. | 51.35M | 1.11% | 78,681 | 25.21M |
| 419 | SGMO | Sangamo Therapeutics, Inc. | 49.88M | -9.34% | 14,503,837 | 39.55M |
| 420 | TELO | Telomir Pharmaceuticals, Inc. | 48.48M | -2.76% | 2,451,186 | - |
| 421 | CUE | Cue Biopharma, Inc. | 48.34M | 14.23% | 69,384 | 27.47M |
| 422 | RADX | Radiopharm Theranostics Limited | 48.05M | -1.61% | 15,960 | 10.86M |
| 423 | RLYB | Rallybio Corporation | 47.87M | 1.91% | 39,399 | 858.00K |
| 424 | NTRB | Nutriband Inc. | 47.71M | 3.56% | 4,796 | 2.28M |
| 425 | HYPD | Hyperion DeFi, Inc. | 47.16M | 4.55% | 53,330 | 813.46K |
| 426 | XLO | Xilio Therapeutics, Inc. | 46.78M | 3.85% | 2,729 | 43.77M |
| 427 | ATOS | Atossa Therapeutics, Inc. | 46.67M | 2.65% | 15,606 | - |
| 428 | DWTX | Dogwood Therapeutics, Inc. | 46.09M | 2.22% | 28,353 | - |
| 429 | MREO | Mereo BioPharma Group plc | 43.16M | -2.17% | 566,896 | 500.00K |
| 430 | LITS | Lite Strategy, Inc. | 41.45M | -0.87% | 106,999 | - |
| 431 | LIXT | Lixte Biotechnology Holdings, Inc. | 40.78M | 0.29% | 3,149 | - |
| 432 | ATRA | Atara Biotherapeutics, Inc. | 40.25M | 7.00% | 43,053 | 120.77M |
| 433 | PSTV | Plus Therapeutics, Inc. | 40.01M | 4.11% | 47,879 | 5.21M |
| 434 | PTN | Palatin Technologies, Inc. | 39.98M | 4.64% | 1,434 | 8.96M |
| 435 | RNXT | RenovoRx, Inc. | 38.31M | 2.31% | 64,452 | 1.12M |
| 436 | ALGS | Aligos Therapeutics, Inc. | 37.62M | 1.84% | 17,620 | 2.19M |
| 437 | SNSE | Sensei Biotherapeutics, Inc. | 37.60M | -0.87% | 16,994 | - |
| 438 | INMB | INmune Bio Inc. | 37.22M | 5.26% | 84,123 | 50.00K |
| 439 | RNTX | Rein Therapeutics Inc. | 37.01M | 3.53% | 334,234 | - |
| 440 | VERU | Veru Inc. | 36.11M | 0.45% | 13,903 | 16.89M |
| 441 | EVAX | Evaxion A/S | 35.86M | 0.94% | 6,028 | 7.53M |
| 442 | PLUR | Pluri Inc. | 34.99M | 1.78% | 681 | 1.34M |
| 443 | HOWL | Werewolf Therapeutics, Inc. | 34.97M | 5.82% | 151,818 | 1.14M |
| 444 | ATNM | Actinium Pharmaceuticals, Inc. | 34.92M | -4.27% | 44,920 | 90.00K |
| 445 | CRVO | CervoMed Inc. | 34.44M | 1.92% | 7,504 | 4.01M |
| 446 | GRCE | Grace Therapeutics, Inc. | 33.42M | 2.86% | 221,593 | - |
| 447 | QNTM | Quantum BioPharma Ltd. | 33.23M | -2.08% | 306,741 | - |
| 448 | DARE | Daré Bioscience, Inc. | 32.76M | 7.14% | 98,430 | 1.03M |
| 449 | NXTC | NextCure, Inc. | 32.47M | 2.01% | 21,015 | - |
| 450 | BOLD | Boundless Bio, Inc. | 32.38M | -0.34% | 25,034 | - |
| 451 | IGC | IGC Pharma, Inc. | 31.17M | 1.82% | 224,472 | 1.11M |
| 452 | SKYE | Skye Bioscience, Inc. | 30.59M | -2.59% | 25,710 | - |
| 453 | TVRD | Tvardi Therapeutics, Inc. | 29.79M | 3.76% | 15,351 | - |
| 454 | NRSN | NeuroSense Therapeutics Ltd. | 29.52M | 3.98% | 163,076 | - |
| 455 | SNTI | Senti Biosciences Holdings, Inc. | 29.44M | -3.91% | 190,000 | 22.00K |
| 456 | BCTX | BriaCell Therapeutics Corp. | 29.15M | 2.49% | 60,415 | - |
| 457 | KYNB | Kyntra Bio, Inc. | 29.10M | 1.99% | 2,250 | 6.44M |
| 458 | TPST | Tempest Therapeutics, Inc. | 28.97M | 16.09% | 238,847 | - |
| 459 | LSTA | Lisata Therapeutics, Inc. | 28.68M | -1.40% | 1,659 | 170.00K |
| 460 | DYAI | Dyadic International, Inc. | 28.61M | 3.62% | 3,072 | 3.09M |
| 461 | PLRZ | Polyrizon Ltd. | 28.49M | 1.65% | 27,057 | - |
| 462 | NEUP | Neuphoria Therapeutics Inc. | 27.99M | 0.03% | 14,407 | 14.99M |
| 463 | APLM | Apollomics, Inc. | 27.91M | -0.57% | 1,693 | 8.99M |
| 464 | CELU | Celularity Inc. | 27.19M | -1.78% | 44,110 | 40.58M |
| 465 | TVGN | Tevogen Bio Holdings Inc. | 27.07M | 1.25% | 1,116 | - |
| 466 | NNVC | NanoViricides, Inc. | 26.38M | 0.13% | 52,604 | - |
| 467 | JSPR | Jasper Therapeutics, Inc. | 26.14M | 4.87% | 66,090 | - |
| 468 | OTLK | Outlook Therapeutics, Inc. | 26.13M | -2.57% | 1,716,975 | 205.70K |
| 469 | BRNS | Barinthus Biotherapeutics plc | 25.73M | 5.02% | 16,574 | 14.97M |
| 470 | ABVC | ABVC BioPharma, Inc. | 25.45M | - | 26,364 | 797.92K |
| 471 | LGVN | Longeveron Inc. | 24.89M | -1.78% | 124,336 | 1.20M |
| 472 | CVM | CEL-SCI Corporation | 24.60M | 4.47% | 13,056 | - |
| 473 | MRKR | Marker Therapeutics, Inc. | 24.34M | 0.69% | 18,933 | 3.55M |
| 474 | AEON | AEON Biopharma, Inc. | 24.19M | 0.15% | 38,034 | - |
| 475 | OSRH | OSR Holdings, Inc. | 24.08M | 58.00% | 203,624,981 | 2.91M |
| 476 | LTRN | Lantern Pharma Inc. | 23.65M | 6.57% | 82,046 | - |
| 477 | VTGN | Vistagen Therapeutics, Inc. | 23.60M | -0.05% | 110,428 | 789.00K |
| 478 | CRIS | Curis, Inc. | 23.04M | 2.64% | 65,629 | 9.44M |
| 479 | SER | Serina Therapeutics, Inc. | 21.80M | -3.28% | 15,258 | 130.00K |
| 480 | VYNE | VYNE Therapeutics Inc. | 21.60M | 1.92% | 13,010 | 570.00K |
| 481 | ALLR | Allarity Therapeutics, Inc. | 21.47M | -1.63% | 41,932 | 320.00K |
| 482 | XCUR | Exicure, Inc. | 21.03M | -0.30% | 3,555 | 500.00K |
| 483 | NCEL | NewcelX Ltd. | 19.94M | 27.92% | 78,366 | - |
| 484 | QNCX | Quince Therapeutics, Inc. | 19.81M | -1.22% | 212,386 | - |
| 485 | COCP | Cocrystal Pharma, Inc. | 19.72M | 2.92% | 36,569 | - |
| 486 | LPCN | Lipocine Inc. | 18.94M | 3.06% | 57,219 | 1.98M |
| 487 | CVKD | Cadrenal Therapeutics, Inc. | 18.12M | 5.28% | 39,352 | - |
| 488 | KTTA | Pasithea Therapeutics Corp. | 17.21M | 0.19% | 34,979 | - |
| 489 | PASG | Passage Bio, Inc. | 17.18M | 0.10% | 14,198 | - |
| 490 | ICU | SeaStar Medical Holding Corporation | 16.49M | 6.72% | 20,398 | 1.23M |
| 491 | LEXX | Lexaria Bioscience Corp. | 16.46M | -3.59% | 182,336 | 368.00K |
| 492 | GNTA | Genenta Science S.p.A. | 16.45M | -1.12% | 50,443 | - |
| 493 | TOVX | Theriva Biologics, Inc. | 15.20M | 0.36% | 1,586,449 | - |
| 494 | INAB | IN8bio, Inc. | 14.62M | -1.66% | 33,201 | - |
| 495 | CTXR | Citius Pharmaceuticals, Inc. | 14.61M | 9.73% | 1,050,600 | 3.94M |
| 496 | HIND | Vyome Holdings, Inc. | 14.46M | 0.98% | 4,960 | 319.71K |
| 497 | HOTH | Hoth Therapeutics, Inc. | 14.25M | 4.28% | 131,120 | - |
| 498 | PHIO | Phio Pharmaceuticals Corp. | 14.11M | 2.97% | 42,263 | - |
| 499 | TRAW | Traws Pharma, Inc. | 14.02M | 6.15% | 148,758 | 2.79M |
| 500 | CYCN | Cyclerion Therapeutics, Inc. | 13.86M | -1.20% | 31,341 | 2.07M |